Notizie Evelo Biosciences - EVLO

Ultime notizie

Data	Ora	Fonte	Titolo
26/1/2024	23:30	EDGAR2	Form 15-12G - Securities registration termination [Section..
26/1/2024	23:29	EDGAR2	Form S-8 POS - Securities to be offered to employees in..
26/1/2024	23:27	EDGAR2	Form POS AM - Post-Effective amendments for registration..
26/1/2024	23:26	EDGAR2	Form 8-K - Current report
12/12/2023	13:43	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/12/2023	13:42	EDGAR2	Form DEF 14A - Other definitive proxy statements
04/12/2023	12:04	EDGAR2	Form 8-K - Current report
01/12/2023	13:11	EDGAR2	Form PRE 14A - Other preliminary proxy statements
21/11/2023	12:44	EDGAR2	Form 8-K - Current report
09/11/2023	23:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/2023	02:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
09/11/2023	02:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
09/11/2023	02:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
03/11/2023	21:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
03/11/2023	21:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
03/11/2023	21:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
27/10/2023	23:24	EDGAR2	Form 8-K - Current report
17/10/2023	13:05	EDGAR2	Form 8-K - Current report
17/10/2023	13:00	GLOBE	Evelo Biosciences Announces Top-Line Results From its Phase..
14/9/2023	02:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
14/9/2023	02:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
14/9/2023	02:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
21/8/2023	23:25	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
21/8/2023	13:43	EDGAR2	Form 8-K - Current report
18/8/2023	06:15	EDGAR2	Form EFFECT - Notice of Effectiveness
14/8/2023	14:14	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/2023	13:42	EDGAR2	Form 8-K - Current report
14/8/2023	13:30	GLOBE	Evelo Biosciences Announces Second Quarter Financial Results..
10/8/2023	22:02	EDGAR2	Form S-3 - Registration statement under Securities Act of..
10/8/2023	02:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/8/2023	02:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/8/2023	02:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
20/7/2023	22:21	EDGAR2	Form 8-K - Current report
18/7/2023	13:27	IHMARKETNEWS	Tuesday’s Wall Street Highlights: Novartis, BofA, Dollar..
12/7/2023	22:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/7/2023	22:06	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
12/7/2023	13:55	EDGAR2	Form 8-K - Current report
12/7/2023	13:30	GLOBE	Evelo Biosciences Closes $25.5 Million Private Placement
10/7/2023	13:36	EDGAR2	Form 8-K - Current report
10/7/2023	13:30	GLOBE	Evelo Biosciences Announces $25.5 Million Private Placement
07/7/2023	22:06	EDGAR2	Form 8-K - Current report
29/6/2023	23:10	EDGAR2	Form 8-K - Current report
29/6/2023	15:00	GLOBE	Evelo Biosciences Announces Reverse Stock Split Effective

Apertura:	Min:	Max:
Chiusura: 0,3165

Evelo Biosciences Inc

EVLO

Borsa: NASDAQ

Tipo: Azione

Valuta: USD

Ultime notizie

La tua Cronologia

Più Attivi

Toplist

Evelo Biosciences Inc

EVLO

Borsa: NASDAQ

Tipo: Azione

Valuta: USD

Ultime notizie

La tua Cronologia